Hematologist
CION Cancer Clinics
Switching your CML tablet: why it happens and what changes | CION Cancer Clinics
Most TKI switches in CML happen for one of two reasons: side effects you cannot live with, or a BCR-ABL level that is not falling as expected. Switching is common and planned. Your haematologist first tries to ease the problem, checks for missed doses and clashing medicines, and may order a mutation test. Never change, skip or stop a TKI yourself. At CION Cancer Clinics, every leukaemia, MDS and MPN case is reviewed by our haematologist and discussed at a tumour board before a plan is agreed.
BP
Medically reviewed by Dr. Basudev PokhrelConsultant Haematologist · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- Why would a haematologist switch your TKI?
- Which situations usually lead to a switch?
- What happens when your TKI is changed?
- What changes after a switch, and what stays the same?
- What do people fear about switching that is not true?
- What can this page not decide for you?
- Common questions about switching TKIs
The short answer
Why would a haematologist switch your TKI?
A TKI is usually switched for one of two reasons: the side effects are too hard to live with, or the BCR-ABL level is not falling as it should. Switching is common in CML and is a planned step, not a sign that treatment has run out.
Side effects come first more often than you might think
Most people who change tablets do so because of how they feel. Cramps that wake you at night, loose motions that stop you going to work, or tiredness that does not lift can all justify a change. So can a quieter problem found on a test, such as rising blood sugar, cholesterol or liver readings. Your haematologist will usually try to ease the problem first, with timing, food or supportive medicine, before moving to a new tablet.
When the numbers are the reason
If BCR-ABL stays high at a checkpoint, or starts rising after it had fallen, the tablet may no longer be controlling the leukaemia. In that case your team first checks that doses have not been missed and that no other medicine is getting in the way. A mutation test is often sent before a new TKI is chosen, because some gene changes rule certain tablets out.
Never switch, skip or stop a TKI yourself, even for a few days. Tell your haematologist what is happening and let the team plan the change.
!
Symptoms that cannot wait for the next visit
If you are on any TKI and develop chest pain, sudden breathlessness, weakness or drooping on one side of the face or body, vomiting blood, black stools or bleeding that will not stop, go to the nearest emergency department now or call 108. Take your tablet strip and your latest reports with you. Do not wait to see whether it settles, and do not take an extra or missed dose to make up.
Not sure whether this applies to you?
Ask an oncologistThe reasons
Which situations usually lead to a switch?
Your haematologist weighs how serious the problem is against how well the current tablet is working.
Side effects you cannot live with
Persistent cramps, puffiness, rashes, loose motions or deep tiredness that remain after simple fixes have been tried.
Often tried first
- Changing when or how the tablet is taken
- Supportive medicine for the symptom
- A short planned pause, set by the team
A problem found on a test
Low blood counts, rising liver or pancreas readings, fluid around the lungs, or changes in heart rhythm, sugar or cholesterol.
BCR-ABL not falling enough
Missing an expected checkpoint, or losing a response you had reached. A mutation test usually comes before the choice of the next tablet.
A new illness or medicine
Heart disease, diabetes or a medicine that clashes with your TKI can make a different tablet safer for you.
Life plans and access
Plans for pregnancy, trouble getting the tablet every month, or a change in cover can all be discussed openly.
Step by step
What happens when your TKI is changed?
-
The problem is written down
Your haematologist records the side effect or the BCR-ABL trend, and checks how regularly the tablets have been taken. Honest answers here help you.
-
Other causes are ruled out
Other medicines, herbal products, missed doses and food timing are reviewed. Sometimes these explain the problem and no switch is needed.
-
Tests before choosing
If response is the concern, a mutation test and sometimes a bone marrow test are sent. If a side effect is the concern, heart, lung, sugar or liver checks may be done.
-
The new tablet is chosen with you
The team explains why this one, what it may cause and how to take it. Ask about cost and supply before you leave.
-
Closer monitoring at first
Blood counts and BCR-ABL are checked more often in the early months on the new TKI, so any trouble is caught early.
Before and after
What changes after a switch, and what stays the same?
What may change
What stays the same
The type of side effects you notice
The need to take your tablet every day
Whether you take it with food or on an empty stomach
Regular BCR-ABL blood tests to track response
Which extra checks are needed, such as heart or sugar tests
Telling every doctor you see that you take a TKI
Monthly cost and where you get the tablet
Avoiding grapefruit and checking new medicines first
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Commonly believed
What do people fear about switching that is not true?
"If I complain about side effects, they will take me off treatment."
The opposite is true. Hidden side effects are the commonest reason people quietly miss doses, and missed doses are what put control at risk. Speaking up lets your team fix the problem or find a tablet you can keep taking.
"A second TKI means the leukaemia is out of control."
Most switches are for side effects while the leukaemia remains well controlled. Even when response is the reason, a later tablet brings BCR-ABL back down for many people.
"The new tablet will have the same side effects."
Each TKI has its own pattern. Someone with cramps on one tablet may have none on another, though new effects can appear. Your team will tell you what to watch for.
"We can buy a different TKI from the chemist and try it."
Changing on your own risks a gap in control and effects nobody is watching. Every switch needs a plan, a mutation check where relevant, and closer tests afterwards.
Being straight with you
What can this page not decide for you?
It cannot tell you whether your side effect is serious enough to switch, or which tablet to move to. That depends on your heart, lungs, sugar, liver, other medicines and your BCR-ABL results together.
Who a switch may not suit
If your leukaemia is well controlled and the side effect is mild or easing, staying on the same tablet is often wiser. A newer tablet may also not suit someone with heart disease, diabetes or lung trouble. And if your disease has moved beyond chronic phase, simply changing the TKI may not be enough, and the plan may include other treatment.
How to prepare for the conversation
Keep a short diary of side effects, noting when each started and how it affects work or sleep. Bring every BCR-ABL report in order and a list of all medicines, including herbal ones. If a family member helps you remember doses, bring them along.
CION's haematology team reviews CML cases with a tumour board and can explain your options, including where a test is done at a partner centre.Questions we are asked
Common questions about switching TKIs
How bad do side effects need to be before switching?
There is no fixed line. If a side effect affects work, sleep or daily life, or leads you to skip doses, tell your haematologist. Many problems can be eased without a switch. If they cannot, a change is reasonable even when the leukaemia is well controlled.
Will switching reset my progress?
Usually not. If you switch because of side effects while BCR-ABL is low, the new tablet generally keeps it low. Your blood tests are checked more often at first to confirm this. If you switch because of poor response, the aim is to bring the level down again.
Is there a gap between the old and new tablet?
Sometimes a short break is planned so a side effect or a low count can recover. Sometimes the change is made straight away. Your haematologist decides this and tells you the exact day to start. Do not create a gap yourself, even while waiting for the new tablet.
Why do I need a mutation test before switching?
When BCR-ABL is not falling or is rising, a change in the gene may be the cause. Some changes stop particular TKIs from working. Knowing this first helps your team avoid a tablet that is unlikely to help. It is not usually needed when the switch is only for side effects.
Can I switch back to my old tablet later?
Sometimes, if the reason for leaving it no longer applies. For example, a side effect may have settled for other reasons. It is rarely done when the original tablet stopped controlling the leukaemia. Your haematologist will look at your full history before suggesting it.
Will a newer TKI cost more?
Often yes, though generics have made some much more affordable in India. Ask whether Aarogyasri, PM-JAY, CGHS, ECHS, EHS or your insurer covers the new tablet, and check the current rules as they change. Raise cost openly, because a tablet you cannot afford every month is not safe.
My father hides his side effects. What should we do?
This is common, especially when someone fears being taken off treatment. Gently explain that reporting side effects protects his treatment. Offer to note symptoms together and come to the next visit. Hearing from the haematologist that options exist often makes it easier to speak.
How long before I know the new tablet is working?
BCR-ABL is usually rechecked within the first few months on a new TKI. Side effects often show earlier. Your haematologist will set the checkpoints for your situation and explain what result they hope to see at each one.
Your Haematologist
Meet CION's haematologist. One specialist for your blood report and your plan.
Dr. Basudev Pokhrel reviews blood counts, transfusion needs and blood disorders, and works with the CION tumour board on blood cancers.
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Patient stories
Hear it from people we have treated
Every story is a video, in the patient's own words. Nothing here is a written testimonial.
Sources
- National Cancer Institute — Chronic Myeloid Leukemia Treatment (PDQ) - Patient Version
- American Cancer Society — Chronic Myeloid Leukemia (CML)
- Macmillan Cancer Support — Chronic myeloid leukaemia (CML)
- Leukemia & Lymphoma Society — Chronic Myeloid Leukemia
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
First, Second and Third Generation TKIs ComparedHow the tablets you might switch to differBCR-ABL Mutation Testing After TKI FailureThe test often sent before a switchTKI Side Effects That Persist Long TermSide effects that linger and how they are managedChronic Myeloid Leukaemia (CML)The full CML guide
Talk to us
Struggling with your TKI?
Tell us what you are experiencing and share your BCR-ABL reports. CION's haematology team will talk through your options with you.